• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌随机临床试验的特征和研究浪费。

Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.

机构信息

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

JAMA Netw Open. 2021 Sep 1;4(9):e2124760. doi: 10.1001/jamanetworkopen.2021.24760.

DOI:10.1001/jamanetworkopen.2021.24760
PMID:34533573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8449283/
Abstract

IMPORTANCE

The results of numerous large randomized clinical trials (RCTs) have changed clinical practice in gastric cancer (GC). However, research waste (ie, unpublished data, inadequate reporting, or avoidable design limitations) is still a major challenge for evidence-based medicine.

OBJECTIVES

To determine the characteristics of GC RCTs in the past 20 years and the presence of research waste and to explore potential targets for improvement.

DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study of GC RCTs, ClinicalTrials.gov was searched for phase 3 or 4 RCTs registered from January 2000 to December 2019 using the keyword gastric cancer. Independent investigators undertook assessments and resolved discrepancies via consensus. Data were analyzed from August through December 2020.

MAIN OUTCOMES AND MEASURES

The primary outcomes were descriptions of the characteristics of GC RCTs and the proportion of studies with signs of research waste. Research waste was defined as unpublished data, inadequate reporting, or avoidable design limitations. Publication status was determined by searching PubMed and Scopus databases. The adequacy of reporting was evaluated using the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline checklist. Avoidable design limitations were determined based on existing bias or lack of cited systematic literature reviews. In the analyses of research waste, 125 RCTs that ended after June 2016 without publication were excluded.

RESULTS

A total of 262 GC RCTs were included. The number of RCTs increased from 25 trials in 2000 to 2004 to 97 trials in 2015 to 2019, with a greater increase among RCTs of targeted therapy or immunotherapy, which increased from 0 trials in 2000 to 2004 to 36 trials in 2015 to 2019. The proportion of RCTs that were multicenter was higher in non-Asian regions than in Asian regions (50 of 71 RCTs [70.4%] vs 96 of 191 RCTs [50.3%]; P = .004). The analysis of research waste included 137 RCTs, of which 81 (59.1%) were published. Among published RCTs, 65 (80.2%) were judged to be adequately reported and 63 (77.8%) had avoidable design defects. Additionally, 119 RCTs (86.9%) had 1 or more features of research waste. Study settings that included blinding (odds ratio [OR], 0.56; 95% CI, 0.33-0.93; P = .03), a greater number of participants (ie, ≥200 participants; OR, 0.07; 95% CI, 0.01-0.51; P = .01), and external funding support (OR, 0.22; 95% CI, 0.08-0.60; P = .004) were associated with lower odds of research waste. Additionally, 35 RCTs (49.3%) were referenced in guidelines, and 18 RCTs (22.2%) had their prospective data reused.

CONCLUSIONS AND RELEVANCE

To our knowledge, this study is the first to describe the characteristics of GC RCTs in the past 20 years, and it found a research waste burden, which may provide evidence for the development of rational RCTs and reduction of waste in the future.

摘要

重要性

大量随机临床试验(RCT)的结果已经改变了胃癌(GC)的临床实践。然而,研究浪费(即未发表的数据、不充分的报告或可避免的设计缺陷)仍然是循证医学的主要挑战。

目的

确定过去 20 年 GC RCT 的特点和研究浪费的存在,并探讨潜在的改进目标。

设计、设置和参与者:在这项关于 GC RCT 的横断面研究中,使用关键词“胃癌”,在 ClinicalTrials.gov 上搜索了 2000 年 1 月至 2019 年 12 月期间注册的 3 期或 4 期 RCT。独立研究人员进行了评估,并通过共识解决了差异。数据分析于 2020 年 8 月至 12 月进行。

主要结果和措施

主要结果是描述 GC RCT 的特点和存在研究浪费迹象的研究比例。研究浪费被定义为未发表的数据、不充分的报告或可避免的设计缺陷。通过搜索 PubMed 和 Scopus 数据库来确定出版状况。使用 CONSORT 报告指南检查表评估报告的充分性。根据现有的偏见或缺乏引用的系统文献综述来确定可避免的设计缺陷。在研究浪费的分析中,排除了 125 项在 2016 年 6 月后结束且未发表的 RCT。

结果

共纳入 262 项 GC RCT。RCT 的数量从 2000 年至 2004 年的 25 项增加到 2015 年至 2019 年的 97 项,其中靶向治疗或免疫治疗的 RCT 增加更为显著,从 2000 年至 2004 年的 0 项增加到 2015 年至 2019 年的 36 项。非亚洲地区多中心 RCT 的比例高于亚洲地区(70.4%,71/101 RCT 与 50.3%,191/382 RCT;P=0.004)。研究浪费的分析包括 137 项 RCT,其中 81 项(59.1%)已发表。在已发表的 RCT 中,65 项(80.2%)被认为报告充分,63 项(77.8%)存在可避免的设计缺陷。此外,119 项 RCT(86.9%)有 1 项或多项研究浪费特征。研究设置包括盲法(比值比,0.56;95%置信区间,0.33-0.93;P=0.03)、更多的参与者(即≥200 名参与者;比值比,0.07;95%置信区间,0.01-0.51;P=0.01)和外部资金支持(比值比,0.22;95%置信区间,0.08-0.60;P=0.004)与较低的研究浪费可能性相关。此外,35 项 RCT(49.3%)被指南引用,18 项 RCT(22.2%)前瞻性数据被重复使用。

结论和相关性

据我们所知,这是第一项描述过去 20 年 GC RCT 特点的研究,发现了研究浪费负担,这可能为未来合理设计 RCT 和减少浪费提供证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1541/8449283/c6c6d5d8a590/jamanetwopen-e2124760-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1541/8449283/c6c6d5d8a590/jamanetwopen-e2124760-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1541/8449283/c6c6d5d8a590/jamanetwopen-e2124760-g001.jpg

相似文献

1
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.胃癌随机临床试验的特征和研究浪费。
JAMA Netw Open. 2021 Sep 1;4(9):e2124760. doi: 10.1001/jamanetworkopen.2021.24760.
2
Research waste in surgical randomized controlled trials.外科随机对照试验中的研究浪费。
Br J Surg. 2019 Oct;106(11):1464-1471. doi: 10.1002/bjs.11266. Epub 2019 Aug 8.
3
Research waste among randomized controlled trials in ovarian cancer: A cross-sectional study.卵巢癌随机对照试验中的研究浪费:一项横断面研究。
Eur J Surg Oncol. 2024 Jul;50(7):108437. doi: 10.1016/j.ejso.2024.108437. Epub 2024 May 23.
4
[Analysis of characteristics and trends of randomized controlled trials of gastric cancer between 2000 and 2019].2000年至2019年胃癌随机对照试验的特征与趋势分析
Zhonghua Wai Ke Za Zhi. 2022 May 1;60(5):478-485. doi: 10.3760/cma.j.cn112139-202100908-00429.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
[Analysis of characteristics and trends of randomized controlled trials of gastric cancer between 2000 and 2019].2000年至2019年胃癌随机对照试验的特征与趋势分析
Zhonghua Wai Ke Za Zhi. 2022 May 1;60(5):479-486. doi: 10.3760/cma.j.cn112139-20210730-00338.
7
Advancing randomized controlled trials of vascular anomalies: an analysis of trial waste.推进血管异常的随机对照试验:对试验浪费的分析。
Eur J Pediatr. 2024 Nov;183(11):5001-5011. doi: 10.1007/s00431-024-05790-2. Epub 2024 Sep 24.
8
Characteristics and research waste of randomized controlled trials in melanoma.黑素瘤随机对照试验的特征和研究浪费。
Clin Exp Dermatol. 2024 Nov 22;49(12):1611-1618. doi: 10.1093/ced/llae248.
9
Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study.爱尔兰健康研究中随机对照试验的质量、范围和报告标准:一项观察性研究。
Trials. 2020 Jun 8;21(1):494. doi: 10.1186/s13063-020-04396-x.
10
Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.与干预措施方法不当和报告不完整相关的可避免浪费:对撒哈拉以南非洲进行的随机试验的系统评价
Trials. 2017 Jul 5;18(1):291. doi: 10.1186/s13063-017-2034-0.

引用本文的文献

1
Linking Trials to Publications: Enhancing Recall by Identifying Trial Registry Mentions in Full-Text.将试验与出版物相联系:通过在全文中识别试验注册提及内容来提高召回率。
medRxiv. 2025 Jun 10:2025.06.09.25329285. doi: 10.1101/2025.06.09.25329285.
2
A Comprehensive Bibliometric Analysis of Biomedical Research Waste: Current Situation, Development, and Trends.生物医学研究废弃物的综合文献计量分析:现状、发展与趋势
Med Sci Monit. 2025 Jun 27;31:e948390. doi: 10.12659/MSM.948390.
3
Public Disclosure of Results From Artificial Intelligence/Machine Learning Research in Health Care: Comprehensive Analysis of ClinicalTrials.gov, PubMed, and Scopus Data (2010-2023).

本文引用的文献

1
Foam surfaces for preventing pressure ulcers.用于预防压疮的泡沫表面。
Cochrane Database Syst Rev. 2021 May 6;5(5):CD013621. doi: 10.1002/14651858.CD013621.pub2.
2
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?从新冠病毒临床试验中吸取的经验教训:我们是否应该改变临床试验方式?
Can J Cardiol. 2021 Sep;37(9):1353-1364. doi: 10.1016/j.cjca.2021.05.009. Epub 2021 May 30.
3
Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.精准肿瘤学时代的随机临床试验演变。
医疗保健领域人工智能/机器学习研究结果的公开披露:对ClinicalTrials.gov、PubMed和Scopus数据的综合分析(2010 - 2023年)
J Med Internet Res. 2025 Mar 21;27:e60148. doi: 10.2196/60148.
4
Characterization changes and research waste in randomized controlled trials of global gastroesophageal reflux disease and hiatus hernia over the past 20 years.过去20年全球胃食管反流病和食管裂孔疝随机对照试验中的特征变化与研究浪费
Int J Surg. 2025 Mar 1;111(3):2358-2375. doi: 10.1097/JS9.0000000000002227.
5
Advancing randomized controlled trials of vascular anomalies: an analysis of trial waste.推进血管异常的随机对照试验:对试验浪费的分析。
Eur J Pediatr. 2024 Nov;183(11):5001-5011. doi: 10.1007/s00431-024-05790-2. Epub 2024 Sep 24.
6
Exploring trial publication and research waste in COVID-19 randomised trials of hydroxychloroquine, corticosteroids, and vitamin D: a meta-epidemiological cohort study.探讨羟氯喹、皮质类固醇和维生素 D 随机对照试验中 COVID-19 的试验发表和研究浪费:一项荟萃流行病学队列研究。
BMC Med Res Methodol. 2024 Jan 23;24(1):19. doi: 10.1186/s12874-023-02110-4.
7
and health outcomes: An overview of systematic reviews and meta-analyses.与健康结果:系统评价与荟萃分析概述
Front Nutr. 2023 Mar 28;10:1107750. doi: 10.3389/fnut.2023.1107750. eCollection 2023.
8
Characteristics of Artificial Intelligence Clinical Trials in the Field of Healthcare: A Cross-Sectional Study on ClinicalTrials.gov.人工智能临床试验在医疗保健领域的特征:一项在 ClinicalTrials.gov 上的横断面研究。
Int J Environ Res Public Health. 2022 Oct 21;19(20):13691. doi: 10.3390/ijerph192013691.
JAMA Oncol. 2021 May 1;7(5):728-734. doi: 10.1001/jamaoncol.2021.0379.
4
Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis.南亚地区结核病患者中的糖尿病及其对结核病治疗的影响:系统评价和荟萃分析。
Sci Rep. 2021 Jan 22;11(1):2113. doi: 10.1038/s41598-021-81057-2.
5
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.影响医疗保健领域随机试验招募的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2020 Oct 7;10(10):MR000045. doi: 10.1002/14651858.MR000045.pub2.
6
The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.胃癌的变化面貌:流行病学趋势与新型疗法的进展
Cancer Gene Ther. 2021 May;28(5):390-399. doi: 10.1038/s41417-020-00234-z. Epub 2020 Oct 2.
7
Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial.腹腔镜与开腹全胃切除术治疗临床Ⅰ期胃癌的发病率和死亡率:CLASS02 多中心随机临床试验。
JAMA Oncol. 2020 Oct 1;6(10):1590-1597. doi: 10.1001/jamaoncol.2020.3152.
8
Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis.儿童风湿性疾病性葡萄膜炎的流行病学和先进治疗方法:系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Feb 4;15(1):41. doi: 10.1186/s13023-020-1324-x.
9
Effect of docosahexaenoic acid on the recovery of motor function in rats with spinal cord injury: a meta-analysis.二十二碳六烯酸对脊髓损伤大鼠运动功能恢复的影响:一项荟萃分析。
Neural Regen Res. 2020 Mar;15(3):537-547. doi: 10.4103/1673-5374.266065.
10
Studies registered in non-ClinicalTrials.gov accounted for an increasing proportion of protocol registrations in medical research.在医学研究中,非 ClinicalTrials.gov 注册的研究占方案注册的比例逐渐增加。
J Clin Epidemiol. 2019 Dec;116:106-113. doi: 10.1016/j.jclinepi.2019.09.005. Epub 2019 Sep 12.